Image

Global Strongyloidiasis Treatment Market - Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Upcoming Report
  • Jan 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Pharmaceutical
  • Upcoming Report
  • Jan 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Strongyloidiasis Treatment Market, By Type (Acute Strongyloidiasis and Chronic Strongyloidiasis), Diagnosis Tests (Duodenal Aspiration Test, Sputum Culture Test, Stool Test, Complete Blood Count (CBC) Test, and Blood Antigen Test), Treatment Type (First Line Therapy And Second Line Therapy), Dugs Class (Antiparasitic Drugs and Others), End Users (Clinics, Hospitals, and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Strongyloidiasis Treatment Market Market Analysis and Insights: Global Strongyloidiasis Treatment Market

Strongyloidiasis treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.20% in the above-mentioned research forecast period. Increasing incidence and prevalence of patient pool suffering from acute as well as chronic strongyloidiasis anticipated to bolster the forthcoming growth of global strongyloidiasis treatment market.

Moreover, growing awareness regarding strongyloidiasis disease predicted to upsurge the global strongyloidiasis treatment market growth pace. Moreover, growing number of organic and inorganic market strategies by major market players as well as rising per capita income act as tremendous opportunity for the global strongyloidiasis treatment market growth. However, sometimes adverse effect associated with first line treatment such as vomiting, nausea, stomach pain, facial or limb swelling, skin rash, diarrhoea, neurologic adverse events (confusion, seizures, and dizziness), liver injury (hepatitis), sudden drop in blood pressure, and severe skin rash potentially requiring hospitalization which may hamper the growth of global strongyloidiasis treatment market. Moreover, stringent regulations for approval of drugs may constrict the development of global strongyloidiasis treatment market.

Strongyloidiasis refer as a disease induced by a roundworm, or a nematode, in the genus Strongyloides. There are nearly 40 species within this genus which can infect livestock, amphibians, birds, reptiles, and other primates, Strongyloides stercoralis is the primary species that accounts for human disease. Growing initiative activities by major healthcare organization and government bodies anticipated to upsurge the further global strongyloidiasis treatment market growth pace.

This strongyloidiasis treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Strongyloidiasis Treatment Market Scope and Market Size

  • Strongyloidiasis treatment market is segmented on the basis of type, diagnosis test, treatment type, drugs class, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
  • On the basis of type, the strongyloidiasis treatment market is segmented into acute strongyloidiasis and chronic strongyloidiasis.
  • On the basis of diagnosis test, the strongyloidiasis treatment market is segmented into duodenal aspiration test, sputum culture test, stool test, complete blood count (CBC) test, and blood antigen test.
  • On the basis of treatment type, the strongyloidiasis treatment market is segmented into first line therapy and second line therapy.
  • On the basis of drugs class, the strongyloidiasis treatment market is segmented into antiparasitic drugs and others.
  • On the basis of end-users, the strongyloidiasis treatment market is segmented into clinics, hospitals, and others.
  • On the basis of distribution channel, the strongyloidiasis treatment market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.

Strongyloidiasis Treatment Market Country Level Analysis

Strongyloidiasis treatment market is analysed and market size information is provided by country, type, diagnosis test, treatment type, drugs class, end-users and distribution channel as referenced above.

The countries covered in the market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America accounts the largest market share due to the growing of high healthcare expenditure and presence of major market players. Europe accounts the second largest strongyloidiasis treatment market share due to increasing disposable income and growing research and development activities by key players for strongyloidiasis treatment. Asia-Pacific is expected to account for the largest strongyloidiasis treatment market share over coming years for the strongyloidiasis treatment market due to growing awareness regarding strongyloidiasis disease.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Strongyloidiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Strongyloidiasis Treatment Market Share Analysis

Strongyloidiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to strongyloidiasis treatment market.

The major players covered in the strongyloidiasis treatment market are Merck & Co., Inc., LGM Pharma, Dr. Reddy's Laboratories, Zhejiang Hisun Pharmaceutical, Delta Synthetic Co. Ltd., Sun Pharmaceutical Industries Limited, Ajanta Pharma, and Mankind Pharmaceuticals, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us


Frequently Asked Questions